Please login to the form below
New Accounts, September, 2009, PR & Med Ed
New pharmaceutical account wins notified to us by the winning agency for the period July to September 2009 inclusive
New pharmaceutical account wins notified to us by the winning agency for the period July to September 2009 inclusive:
| CLIENT | PRODUCT | THERAPEUTIC AREA | WINNING AGENCY |
| AstraZeneca | n/a | Non-small cell lung cancer | Medaxial Group |
| Biogen Idec | n/a | Neurology | Medaxial Group |
| EMD Serono | Undisclosed | Infertility | Medaxial Group |
| Enturia | ChloraPrep | Surgical skin preparation | Medaxial Group |
| GSK | new product | Haematology | Succinct Healthcare Communications |
| The Hesley Group | n/a | Corporate | Clew Communications |
| Idis | European and UK corporate | Corporate | Ogilvy Healthworld UK |
| LCNDG | n/a | Oncology | Succinct Healthcare Communications |
| Mundipharma International | BruTrans and Targin | Pain | Euro RSCG Life |
| Mundipharma International | n/a | Respiratory | Health 4 Brands |
| Mundipharma International | New product | Pain | Health 4 Brands |
| NECDAG | n/a | Oncology | Succinct Healthcare Communications and Consultancy |
| Nutricia Advanced Medical Nutrition | Respifor | COPD | Virgo HEALTH |
| Nutricia Advanced Medical Nutrition | Conference support | Cross-band | Virgo HEALTH |
Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Pfizer CEO pushes back COVID-19 vaccine submission to November
- Galapagos mid-stage trial failure raises concerns for Gilead deal
- The Truth about Doctors
- Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses
- Novartis scores CHMP backing for cholesterol drug Leqvio
- Novartis scores CHMP backing for cholesterol drug Leqvio
- Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
- FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients
- Moderna completes enrolment of phase 3 COVID-19 vaccine trial
- Vaccine developers call on FDA to offer clarity on COVID-19 trials
- The other side of … blood cancer
- COVID-19 – a catalyst for technology adoption in clinical trials
PMHub
OPEN Health
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...
Latest intelligence
- Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
- The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
- The other side of … blood cancer
- To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
- COVID-19 – a catalyst for technology adoption in clinical trials
- As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...
Quick links
Infographics
